Skip to main content

The Global Importance of Plants as Sources of Medicines and the Future Potential of Chinese Plants

  • Chapter
Drug Discovery and Traditional Chinese Medicine

Abstract

It has been estimated that more than 25% of prescription pharmaceuticals contain plant-derived ingredients yet only a small percentage of the plants in the world have been evaluated for potential pharmaceutical use. Increased efforts to survey plants as sources of new drugs in recent years have stepped up the pace of the discovery of new bioactive compounds from plants, and many programs will continue to contribute to this in the near future. With an estimated 30,000 species of plants, many with a long history of use as traditional medicines, China has played an important role in the development of presently used pharmaceuticals. Chinese plants also have promise to contribute useful medicines in the future. Several factors are contributing to the current interest in Chinese plants, particularly those used in Traditional Chinese Medicine. Recently programs have been initiated for clinical trials of herbal products from Chinese species. In addition, advances in pharmaceutical screening and evaluation of plants against a broader range of targets is increasing the potential for the discovery of new pharmaceutical and nutritional products from Chinese medicinal plants. Plants have always played an important role as a source of medicines both in a western sense and in a traditional sense. This review will cover the historical importance of plants in human health care and will examine three areas in which Chinese plants may be of particular importance in the future. New trends in natural products research have great importance for the potential use of Chinese plants for both the discovery of novel bioactive compounds and also the scientific validation of traditional Chinese medicine.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  • Bernart, M. W., Y. Kashman, M. Tischler, J. H. Cardellina II, and M. R. Boyd. 1993. Bershacolone, an unprecedented diterpene cyclobutene from Maprounea Africana. Tetrahedron Letters 34: 4461–4464.

    Article  CAS  Google Scholar 

  • Bokesch, H. R., T. C. McKee, M. J. Currens, R. J. Gulakowski, J. B. McMahon, J. H. Cardellina II, and M. R. Boyd. 1996. HIV-inhibitory gallotannins from Lepidobotrys staudtii Natural Product Letters 8: 133–136.

    CAS  Google Scholar 

  • Boyd, M. R., Y. F. Hallock, J. H. Cardellina II, K. P. Manfredi, J. W. Blunt, J. B. McMahon, R. W. Buckheit, Jr., G. Bringmann, M. Schäffer, G. M. Cragg, D. W. Thomas, and J. G. Jato. 1994. Anti-HIV michellamines from Ancistrocladus korupensis. J. Med. Chem. 37: 1740–1745.

    Article  PubMed  CAS  Google Scholar 

  • Cragg, G. M., M. R. Boyd, J. H. Cardellina II, M. R. Grever, S. A. Schepartz, K. M. Snader, and M. Suffhess. 1993. Role of plants in the National Cancer Insitute drug discovery and development program. Pp. 80–95. In: A. D. Kinghorn and M. F. Balandrin (eds.) Human Medicinal Agents from Plants. American Chemical Society, Washington, D.C.

    Chapter  Google Scholar 

  • Farnsworth, N. R. 1977. Problems and prospects of discovering new drugs from higher plants by pharmacological screening. Pp. 1–22. In: H. Wagner and P. Wolf (eds.) New natural products with pharmacological, biological, or therapeutic activity. Springer-Verlag, New York.

    Chapter  Google Scholar 

  • Farnsworth, N. R., O. Akerele, A. Bingel, D.D. Soejarto, and Z. Guo. 1985. Medicinal plants in therapy. Bulletin of the World Health Organization 63: 965–981.

    PubMed  CAS  Google Scholar 

  • Grifo, F, D. Newman, A. S. Fairfield, B. Bhattacharya, and J. T. Grupenhoff. 1997. The origins of prescription drugs. Pp. 131–163. In: F. Grifo and J. Rosenthal (eds.) Biodiversity and Human Health. Island Press, Washington, D.C.

    Google Scholar 

  • Hallock, Y. F., K. P. Manfredi, J. W. Blunt, J. H. Cardellina II, M. Schäffer, G. Bringmann, A. Y. Lee, J. Clardy, G. Francois, and M. R. Boyd. 1991. Korupensamines A-D, novel antimalarial alkaloids from Ancistrocladus korupensis. J. Org. Chem. 59: 6349–6355.

    Article  Google Scholar 

  • Kingston, D. G. I., M Abdel-Kader, B.-N. Zhou, S.-W. Yang, J. M. Berger, H. van der Werff, R. Evans, R. Mittermeier, S. Malone, L. Famalare, M. Guerin-McManus, J. H. Wisse, and J. S. Miller. 1999a. Biodiversity conservation, economic development, and drug discovery in Suriname. Pp. 39–59. In: S. J. and H. G. Cutler (eds.) Biologically Active Natural Products: Pharmaceuticals. CRC Press, Boca Raton.

    Google Scholar 

  • Kingston, D. G. I, M. Abdel-Kader, B.-N. Zhoud, S.-W. Yang, J. M. Berger, H. van der Werff, J. S. Miller, R. Evans, R. Mittermeier, L. Famolare, M. Guerin-McManus, S. Malone, R. Nelson, E. Moniz, J. H. Wisse, D. M. Vyas, J. J. K. Wright, and S. Aboikonie. 1999b. The Suriname International Cooperative Biodiversity Group Program: lessons from the first five years. Pharmaceutical Biology 37 (Suppl.): 22–34.

    Article  Google Scholar 

  • Mays, T. D., K. Duffy-Mazan, G. Cragg, and M. Boyd. 1997. A paradigm for the equitable sharing of benefits resulting from biodiversity research and development. Pp. 267–280. In: F. Grifo and J. Rosenthal (eds.) Biodiversity and Human Health. Island Press, Washington, D.C.

    Google Scholar 

  • Miller, J. S. and S. J. Brewer. 1992. The discovery of medicines and forest conservation. Pp. 119–134. In: R. P. and J. E. Adams (eds.) Conservation of Plant Genes Through DNA Banking and in vitro Biotechnology. Academic Press, San Diego.

    Chapter  Google Scholar 

  • Psenak, M. 1998. Biosynthesis of morphinane alkaloids. Pp. 159–188. In: J. Bernath (ed.) Poppy, the Genus Papaver. Harwood Academic Publishers, Amsterdam.

    Google Scholar 

  • Rosenthal, J. 1997. Integrating drug discovery, biodiversity conservation, and economic development: early lessons from the International Cooperative Biodiversity Groups. Pp. 281–301. In: F. Grifo and J. Rosenthal (eds.) Biodiversity and Human Health. Island Press, Washington, D.C.

    Google Scholar 

  • Rosenthal, J., D. Beck, A. Bhat, J. Biswas, L. Brady, K. Bridbord, S. Collins, G. Cragg, J. Edwards, A. Fairfield, M. Gottlieb, L.A. Gschwind, Y. Hallock, R. Hawks, R. Hegyeli, G. Johnson, G. Keusch, E. E. Lyons, R. Miller, J. Rodman, J. Roskoski, and D. Siegel-Causey. 1999. Combining high-risk science with ambitious social and economic goals. Pharmaceutical Biology 37(Suppl.):6–21.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer Science+Business Media New York

About this chapter

Cite this chapter

Miller, J.S. (2001). The Global Importance of Plants as Sources of Medicines and the Future Potential of Chinese Plants. In: Lin, Y. (eds) Drug Discovery and Traditional Chinese Medicine. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1455-8_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-1455-8_4

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-5562-5

  • Online ISBN: 978-1-4615-1455-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics